CDTTW 0.01 Conduit Pharmaceuticals Inc.
| Range: | 0.0148-0.0149 | Vol Avg: | 0 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 2.09 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jan 01 1970 | Empoloyees: | 7 | ||
| CUSIP: | CIK: | ISIN: | Country: | KY | |||
| CEO: | Dr. David Joszef Tapolczay | Website: | https://www.conduitpharma.com | ||||
Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow